140
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The role of phosphorylcholine-specific immune responses in the tonsils and peripheral blood on IgA nephropathy

, &
Pages 1099-1104 | Received 30 Jul 2018, Accepted 06 Sep 2018, Published online: 25 Jan 2019

References

  • Berger J, Hinglais N. [Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris). 1968;74:694–695. French.
  • Chauveau D, Droz D. Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol. 1993;104:1–5.
  • Suzuki H, Kiryluk K, Novak J, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22:1795–1803.
  • Wang Y, Chen J, Wang Y, et al. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:1923–1931.
  • Suzuki S, Nakatomi Y, Sato H, et al. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet. 1994;343:12–16.
  • Suzuki S, Fujieda S, Sunaga H, et al. Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy. Clin Exp Immunol. 2000;119:328–332.
  • Goto T, Bandoh N, Yoshizaki T, et al. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin Immunol. 2008;126:260–269.
  • Kodama S, Suzuki M, Arita M, et al. Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis. Clin Exp Immunol. 2001;123:301–308.
  • Chao TK, Rifai A, Ka SM, et al. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. Kidney Int. 2006;70:283–297.
  • Volanakis JE, Wirtz KW. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature. 1979;281:155–157.
  • Grönwall C, Akhter E, Oh C, et al. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin Immunol. 2012;142:390–398.
  • Carrero JJ, Hua X, Stenvinkel P, et al. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis. Nephrol Dial Transplant. 2009;24:3454–3460.
  • Clinical guides for immunoglobulin A (IgA) nephropathy in Japan, third version. Nihon Jinzo Gakkai Shi. 2011;53:123–135.
  • Béné MC, Hurault De Ligny B, Kessler M, et al. Confirmation of tonsillar anomalies in IgA nephropathy: a multicenter study. Nephron. 1991;58:425–428.
  • Harper SJ, Allen AC, Béné MC, et al. Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol. 1995;101:442–448.
  • Urbaneja MA, Chapman D. The binding of phosphorylcholine-carrying antigens to the anti-phosphorylcholine monoclonal antibody TEPC 15. A fluorescence spectroscopic study. Biochim Biophys Acta. 1989;998:85–90.
  • Shaw PX, Hörkkö S, Chang MK, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest. 2000;105:1731–1740.
  • Suzuki S, Gejyo F, Nakatomi Y, et al. Role of IgA, IgG, and IgM antibodies against Haemophilus parainfluenzae antigens in IgA nephropathy. Clin Nephrol 1996;46:287–295.
  • Grönwall C, Silverman GJ. Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease. J Clin Immunol. 2014;34: S12–S21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.